FDA
approval
· 2024-10-31
FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
The FDA approved a supplemental application for MS CONTIN (morphine sulfate) from Rhodes Pharmaceuticals L.P., indicating an approved supplemental NDA for this …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MS CONTIN (MORPHINE SULFATE)